Search results for "molecular microbiology"

Awarded jointly to Benjamin List and David W.C. MacMillan "for the development of asymmetric organocatalysis"

The MasSpec Pen can authenticate the type and purity of meat samples in as little as 15 seconds

Exhibitor highlights from ESCMID’s annual congress in Amsterdam

Advancements to include CosMx® Whole Transcriptome Panel; enhanced technology engine to power CellScape™ for spatial proteomics; expansion to 1000-plex protein assay on GeoMx® DSP; and launch of PaintScape™, a revolutionary platform enabling direct visualization of the 3D genome

Learn how a US company is changing the paradigm for contract research, combining disease pharmacology, toxicology, and pathology to optimize drug development

Learn more about biophysical characterization technology and how it can help to advance your drug discovery and biotherapeutic workflows

New icIEF technology provides a unique and powerful analysis method to address key analytical challenges

The partnership with Primer Design aims to distribute the Genesig CE-IVD & FDA-EUA COVID-19 qPCR kit to Europe and the U.S.

CLINICAL24 Ambassador, Professor. Joe El-Koury, discusses the importance of automation and custom solutions in clinical chemistry

Agreement will expand the availability of Gencurix’s in vitro diagnostic (IVD) assays using Droplet Digital™ PCR (ddPCR™) for clinical testing of critical oncology biomarkers across Europe

The QUICKVUE Influenza + SARS test is designed for professional use to detect and differentiate between flu A/B and COVID-19 in 10–15 minutes

Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'

The new Krios 5 Cryo-TEM enables breakthroughs in structural and cellular biology to pioneer new treatments and advance drug discovery

With over 40 years of biopharma leadership experience, Dr. Slaoui will help drive innovation and growth for Abzena

A solution for infectious disease research, delivering rapid, flexible, and scalable pathogen detection

Highlighting the impact of ctDNA and NGS for advancing cancer diagnostics and personalized treatment